Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(29 sites)
Australia
GenesisCare Research, Adelaide Southern Oncology Clinical Research Unit (SOCRU), Bedford Park Blacktown Hospital, Blacktown Kinghorn Cancer Centre (KCC), Darlinghurst Austin Health, Heidelberg